MED26
Mediator of RNA polymerase II transcription subunit 26
Also known as: CRSP7, CRSP70, MED26_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95402
- Gene
- MED26
- Ensembl
- ENSG00000105085
- Chromosome
- 19
- Canonical length
- 600 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitotic chromosome
OverviewNCBI Gene
The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
600 residues, UniProt reviewed canonical sequence.
>O95402|MED26
1 MTAAPASPQQ IRDRLLQAID PQSNIRNMVA VLEVISSLEK YPITKEALEE TRLGKLINDV
61 RKKTKNEELA KRAKKLLRSW QKLIEPAHQH EAALRGLAGA TGSANGGAHN CRPEVGAAGP
121 PRSIHDLKSR NDLQRLPGQR LDRLGSRKRR GDQRDLGHPG PPPKVSKASH DPLVPNSSPL
181 PTNGISGSPE SFASSLDGSG HAGPEGSRLE RDENDKHSGK IPVNAVRPHT SSPGLGKPPG
241 PCLQPKASVL QQLDRVDETP GPPHPKGPPR CSFSPRNSRH EGSFARQQSL YAPKGSVPSP
301 SPRPQALDAT QVPSPLPLAQ PSTPPVRRLE LLPSAESPVC WLEQPESHQR LAGPGCKAGL
361 SPAEPLLSRA GFSPDSSKAD SDAASSGGSD SKKKKRYRPR DYTVNLDGQV AEAGVKPVRL
421 KERKLTFDPM TRQIKPLTQK EPVRADSPVH MEQQSRTELD KQEAKASLQS PFEQTNWKEL
481 SRNEIIQSYL SRQSSLLSSS GAQTPGAHHF MSEYLKQEES TRQGARQLHV LVPQSPPTDL
541 PGLTREVTQD DLDRIQASQW PGVNGCQDTQ GNWYDWTQCI SLDPHGDDGR LNILPYVCLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MED26 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- testis: 34 nTPM
- bone marrow: 10 nTPM
- skeletal muscle: 6.7 nTPM
- skin: 6.1 nTPM
- esophagus: 5.1 nTPM
- lymph node: 4.5 nTPM
Single-cell type
- pdcs: 0.6 nCPM
- early spermatids: 0.4 nCPM
- epididymal efferent duct ciliated cells: 0.4 nCPM
- early primary spermatocytes: 0.2 nCPM
- mast cells: 0.2 nCPM
- alveolar cells type 2: 0.1 nCPM
Immune cell
- plasmacytoid DC: 1.4 nTPM
- basophil: 0.7 nTPM
- naive B-cell: 0.7 nTPM
- T-reg: 0.7 nTPM
- gdT-cell: 0.5 nTPM
- memory B-cell: 0.4 nTPM
Brain region
- medulla oblongata: 16 nTPM
- cerebellum: 15 nTPM
- hypothalamus: 15 nTPM
- hippocampal formation: 15 nTPM
- midbrain: 15 nTPM
- pons: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.88
- gnomAD missense Z
- 1.13
- DepMap mean gene effect
- -0.69
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of gene expression
- positive regulation of transcription elongation by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- regulation of transcription by RNA polymerase II
- RNA polymerase II preinitiation complex assembly
- transcription initiation at RNA polymerase II promoter
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type
- Transcription factor IIS, N-terminal
- TFIIS/LEDGF domain superfamily
- TFIIS helical bundle-like domain
- Mediator complex subunit 26, C-terminal domain
- Mediator complex subunit 26, middle domain
- Mediator of RNA polymerase II transcription subunit 26
- Mediator complex subunit 26 C-terminal
- Mediator complex subunit 26 middle domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MED26 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MED26 as an antibody target. Whether an autoantibody or antibody against MED26 could matter depends on whether native MED26 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MED26 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MED26 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...